Fair Value Measurement (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis |
The following tables present the Company’s fair value hierarchy for its financial instruments that are measured at fair value on a recurring basis (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
10,639 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
10,639 |
|
Commercial paper |
|
$ |
— |
|
|
$ |
11,991 |
|
|
$ |
— |
|
|
$ |
11,991 |
|
|
|
$ |
10,639 |
|
|
$ |
11,991 |
|
|
$ |
— |
|
|
$ |
22,630 |
|
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper |
|
$ |
— |
|
|
$ |
35,466 |
|
|
$ |
— |
|
|
$ |
35,466 |
|
U.S. treasury bills and bonds |
|
|
17,392 |
|
|
|
— |
|
|
|
— |
|
|
|
17,392 |
|
|
|
$ |
17,392 |
|
|
$ |
35,466 |
|
|
$ |
— |
|
|
$ |
52,858 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Credit Agreement Warrants |
|
$ |
— |
|
|
$ |
383 |
|
|
$ |
— |
|
|
$ |
383 |
|
|
|
$ |
— |
|
|
$ |
383 |
|
|
$ |
— |
|
|
$ |
383 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
$ |
6,360 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,360 |
|
|
|
$ |
6,360 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
6,360 |
|
Marketable securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper |
|
$ |
— |
|
|
$ |
44,543 |
|
|
$ |
— |
|
|
$ |
44,543 |
|
U.S. treasury bills and bonds |
|
|
12,426 |
|
|
|
— |
|
|
|
— |
|
|
|
12,426 |
|
|
|
$ |
12,426 |
|
|
$ |
44,543 |
|
|
$ |
— |
|
|
$ |
56,969 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Long-term liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Credit Agreement Warrants |
|
$ |
— |
|
|
$ |
106 |
|
|
$ |
— |
|
|
$ |
106 |
|
|
|
$ |
— |
|
|
$ |
106 |
|
|
$ |
— |
|
|
$ |
106 |
|
|
| Schedule of Cash and Cash Equivalents |
The following tables summarize the Company’s cash, cash equivalents, and marketable securities by significant category (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
|
Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
$ |
16,184 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
16,184 |
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
|
10,639 |
|
|
|
— |
|
|
|
— |
|
|
|
10,639 |
|
Commercial paper |
|
|
11,991 |
|
|
|
— |
|
|
|
— |
|
|
|
11,991 |
|
|
|
$ |
38,814 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
38,814 |
|
Marketable Securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper |
|
$ |
35,498 |
|
|
$ |
1 |
|
|
$ |
(33 |
) |
|
$ |
35,466 |
|
U.S. treasury bills and bonds |
|
|
17,402 |
|
|
|
— |
|
|
|
(10 |
) |
|
|
17,392 |
|
|
|
$ |
52,900 |
|
|
$ |
1 |
|
|
$ |
(43 |
) |
|
$ |
52,858 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2025 |
|
|
|
Amortized Cost |
|
|
Unrealized Gains |
|
|
Unrealized Losses |
|
|
Fair Value |
|
Cash and cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
$ |
18,453 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
18,453 |
|
Cash equivalents: |
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds |
|
|
6,360 |
|
|
|
— |
|
|
|
— |
|
|
|
6,360 |
|
U.S. treasury bills and bonds |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
$ |
24,813 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
24,813 |
|
Marketable Securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper |
|
$ |
44,514 |
|
|
$ |
29 |
|
|
$ |
— |
|
|
$ |
44,543 |
|
U.S. treasury bills and bonds |
|
|
12,423 |
|
|
|
3 |
|
|
|
— |
|
|
|
12,426 |
|
|
|
$ |
56,937 |
|
|
$ |
32 |
|
|
$ |
— |
|
|
$ |
56,969 |
|
|
| Amortized Cost and Estimated Fair Value of Marketable Securities |
The following table represents amortized cost and estimated fair value of marketable securities, by contractual maturity (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
|
|
|
|
|
Amortized Cost |
|
|
Fair Value |
|
Due in one year or less |
|
|
|
|
|
$ |
52,900 |
|
|
$ |
52,858 |
|
|
| Credit Agreement Warrants |
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] |
|
| Schedule of Quantitative Information Contingent Earnout Liability |
The table below quantifies the significant inputs used for the Credit Agreement Warrants:
|
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
|
December 31, |
|
|
|
2026 |
|
|
|
2025 |
|
Fair value of the Company’s Class A common stock |
$ |
|
18.60 |
|
|
$ |
|
7.50 |
|
Exercise price |
$ |
16.08 |
|
|
$ |
16.08 |
|
Risk-free interest rate |
|
|
4.19 |
% |
|
|
|
3.94 |
% |
Expected volatility factor |
|
|
102.5 |
% |
|
|
|
75.0 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
|
— |
% |
Remaining contractual term (in years) |
|
|
6.0 |
|
|
|
|
6.5 |
|
|